Profiles of researchers at Massachusetts General Hospital
Profiles of researchers at Massachusetts General Hospital

Dennis Brown, PhD, studies the many impacts of water imbalance in the body

Dr. Brown, Director of the Massachusetts General Hospital Program in Membrane Biology, is looking at the body as a system of water transportation with the goal of generating treatments for life-threatening water balance disorders.

Fatima Cody Stanford, MD, MPH, MPA, addresses barriers and disparities in obesity treatment

Dr. Stanford, an Obesity Medicine Physician at the Massachusetts General Hospital Weight Center, an Associate at the Mass General Disparities Solution Center, and Associated Faculty at the Mass General Mongan Institute for Health Policy, is taking a holistic approach to both treat and advocate for patients who have obesity.

Q&A with Emily Hyle, MD, MSc

Dr. Hyle is an infectious disease clinician investigator at Massachusetts General Hospital, is investigating ways to improve outcomes for patients with HIV and to measure the effectiveness of medical interventions to prevent disease transmission during international travel.

Levison makes a dramatic bid to improve HIV care adherence by Latino immigrants

A dramatic video illustrating the consequences of letting HIV care lapse is being tested as a public health intervention in the Latino immigrant community.

Valera works to help the hidden victims of traumatic brain injury

Eve Valera, PhD, a researcher at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital, is working to learn more about the traumatic brain injuries suffered by women in abusive relationships.

Goldberg looks forward to mentoring the next generation of scientists in her new role

Marcia Goldberg, MD, the new Director of the Postdoctoral Division at Massachusetts General Hospital, hopes to make a positive impact on the next generation of scientists by providing mentorship and career advice.

MacArthur's first-of-its-kind exome browser helps to further research into rare diseases

It has often been said that searching for genetic clues to rare disease is like looking for a needle in a haystack. It’s even more difficult when you’re not sure what makes the needle different from the hay.

That was essentially the challenge facing researchers in rare disease genetics up until two years ago, when a team led by Daniel MacArthur, PhD, launched the Exome Aggregation Consortium (ExAC) database.

Firth takes his research to extremes

Pediatric anesthesiologist Paul Firth, MBChB, has spent the past two decades studying the medical case histories of mountain climbers and other adventurers to create a more complete picture of how the body functions in extreme conditions.

Widge and Katnani hope that new approach to deep brain stimulation could bring more patients into the treatment loop

Researchers Alik Widge, MD, PhD, and Husam Katnani, PhD, are part of a team that is working on a more nuanced approach to deep brain stimulation that could help patients with traumatic brain injuries, treatment resistant depression and post traumatic stress disorder.

Lesser is working to turn harmful bacteria into a tool for healing

Cammie Lesser, MD, PhD, has always been fascinated by the way bacterial pathogens manipulate cells inside the human body. She likens the push and pull between bacterial aggression and human response as a struggle similar to warfare on the microbiological level.

Rajagopal Lab identifies process for generating adult stem cells outside the body

A new process that makes it possible to replicate adult human stem cells in the lab has the potential to provide researchers with game-changing insights into the progression of diseases in the lungs and other organs.

Bernstein uses genomics to study gene activity in stem cells and cancers

A conversation with Brad Bernstein, MD, PhD, the inaugural Bernard and Mildred Kayden Endowed MGH Research Institute Chair.

Industry collaboration leads to new clinical trial

John Stone, MD, MPH, is developing a new clinical trial to investigate a treatment for IgG-4 related disease, a condition that causes the growth of excessive fibrous tissue in the organs and is often misdiagnosed as lymphoma.

Back to Top